Delivery Order SPE2DB24D2102-SPE2DB24FJHTH

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg Viberzi tablets. The $2,648.37 firm-fixed-price contract has an ultimate completion date of October 10, 2024. AmerisourceBergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide range of essential pharmaceutical products and medical supplies to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,707.63 firm fixed price contract is for the delivery of Viberzi 100 mg Tablets in quantities of 60. The contract has a performance period ending on May 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which allows the company to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,883.20 firm fixed-price contract is for the delivery of 60 tablets of the medication Viberzi 75 mg. The contract has an ultimate completion date of April 29, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,138.42, is for the delivery of the drug Viberzi 100 mg tablets in 60-count packages. The contract is a firm fixed-price type with a completion date of January 29, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,392.32 contract is for the delivery of 60 tablets of the pharmaceutical product Viberzi 100 mg. The contract has a performance period that runs through May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIBERZI 100 mg tablets. The contract has a ceiling value of $1,953.62 and runs through September 23, 2024. It is a firm fixed price contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,450.84 firm-fixed-price contract is for the supply of the pharmaceutical product Viberzi 100 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,707.63, is for the supply of the prescription medication Viberzi 75 mg tablets. The contract is a firm fixed-price delivery order with a completion date of May 14, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,949.61 firm-fixed-price contract is for the delivery of VIBERZI 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Viberzi 75 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $2,970.77 and a period of performance ending on September 10, 2024. The contract was not set aside for any specific socioeconomic program. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
  • SPE2DB24D2102
    Indefinite Delivery Contract
  • SPE2DB24D2102-SPE2DB24FJHTH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Viberzi 100 mg tablets. The contract has a firm fixed price of $2,133.20 and an ultimate completion date of August 23, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for the provision of a wide range of pharmaceutical and medical supplies to support federal healthcare programs and military treatment facilities nationwide. These IDCs, valued at up to $999,999,999 and $750,000 respectively, serve as primary vehicles for AmerisourceBergen to efficiently deliver critical medical commodities to various government agencies and beneficiaries.

Generated 11/21/24, 9:34 AM